Hugo Arias-Pulido

8PUBLICATIONS
26CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2026
Characterization of Anti-Canine PD-1 Antibodies.

|Sep 14, 2024
An Abscopal Effect on Lung Metastases in Canine Mammary Cancer Patients Induced by Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles and Anti-Canine PD-1.

Petra Sergent, Juan Carlos Pinto-Cárdenas, Adhara Jaciel Arreguin Carrillo

|Sep 28, 2023
Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients.

Guillermo Valdivia, Daniel Alonso-Miguel, Maria Dolores Perez-Alenza

|Sep 23, 2022
Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes.

Daniel Alonso-Miguel, Steven Fiering, Hugo Arias-Pulido

|Mar 12, 2022
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer.

Daniel Alonso-Miguel, Guillermo Valdivia, Diego Guerrera

|Sep 20, 2021
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.

Hugo Arias-Pulido, Ashley Marie Cimino-Mathews, Nabila Chaher

Pageof 2

Frequent Collaborators

4 joint publications

Steven N Fiering

4 joint publications

Daniel Alonso-Miguel

3 joint publications

Johannes Vom Berg

3 joint publications

Nicole F Steinmetz